Back to HomeBeta

ICD-10 Coding for Steatosis(K76.0, K75.8, K70.10)

Complete ICD-10-CM coding and documentation guide for Steatosis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Fatty LiverHepatic SteatosisNonalcoholic Fatty Liver Disease (NAFLD)

Related ICD-10 Code Ranges

Complete code families applicable to Steatosis

K70-K77Primary Range

Diseases of liver

This range includes codes for liver diseases, including steatosis and its variants.

Metabolic disorders

Includes codes for metabolic dysfunction-associated steatotic liver disease (MASLD).

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
K76.0Fatty (change of) liver, not elsewhere classifiedUse for simple steatosis without specified etiology.
  • Ultrasound showing hyperechoic parenchyma
  • CT scan with liver attenuation ≤40 HU
K75.8Other specified inflammatory liver diseasesUse when biopsy confirms NASH.
  • Biopsy showing steatohepatitis with inflammation
  • HA ≥55 µg/L, AST ≥45 IU/L
K70.10Alcoholic hepatitis without ascitesUse when alcohol is the confirmed etiology of hepatitis.
  • Documentation of alcohol use
  • AST:ALT ratio ≥0.8

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for steatosis

Essential facts and insights about Steatosis

The ICD-10 code for steatosis is K76.0, used for fatty liver not elsewhere classified.

Primary ICD-10-CM Codes for steatosis

Fatty (change of) liver, not elsewhere classified
Billable Code

Decision Criteria

clinical Criteria

  • Presence of hepatic steatosis on imaging without alcohol use.

documentation Criteria

  • Absence of terms like 'alcoholic' or 'NASH' in documentation.

Applicable To

  • Hepatic steatosis
  • Fatty liver

Excludes

  • Alcoholic liver disease (K70.-)
  • Nonalcoholic steatohepatitis (K75.8)

Clinical Validation Requirements

  • Ultrasound showing hyperechoic parenchyma
  • CT scan with liver attenuation ≤40 HU

Code-Specific Risks

  • Risk of undercoding if etiology is not specified.

Coding Notes

  • Ensure documentation specifies absence of alcohol use if coding K76.0.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Metabolic dysfunction-associated steatotic liver disease (MASLD)

E88.81
Use when steatosis is associated with metabolic syndrome.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Other specified inflammatory liver diseases

K75.8
Use when biopsy confirms steatohepatitis with inflammation.

Fatty (change of) liver, not elsewhere classified

K76.0
Use K76.0 for simple steatosis without inflammation.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Steatosis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code K76.0.

Impact

Clinical: Inaccurate diagnosis and treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims or reduced reimbursement.

Mitigation Strategy

Use specific terms and document etiology clearly.

Impact

Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on liver disease etiology.

Mitigation Strategy

Use K71.- for drug-induced liver disease.

Impact

Reimbursement: Potential for reduced reimbursement., Compliance: Failure to meet specificity requirements., Data Quality: Loss of specificity in clinical data.

Mitigation Strategy

Use specific codes like K70.10 if alcohol-related.

Impact

High risk of audit if unspecified codes are used without supporting documentation.

Mitigation Strategy

Ensure documentation supports the specificity of the code used.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Steatosis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Steatosis

Use these documentation templates to ensure complete and accurate documentation for Steatosis. These templates include all required elements for proper coding and billing.

Gastroenterology Progress Note

Specialty: Gastroenterology

Required Elements

  • Biopsy results
  • Liver function tests
  • Imaging findings

Example Documentation

Assessment: Nonalcoholic steatohepatitis (NASH) - Biopsy: Macrovesicular steatosis (30%), lobular inflammation, perisinusoidal fibrosis - Labs: AST 48, ALT 50, HA 62 µg/L - Imaging: MRI-PDFF 18% - Plan: Code K75.8 + E88.81

Examples: Poor vs. Good Documentation

Poor Documentation Example
Fatty liver noted.
Good Documentation Example
CT abdomen shows macrovesicular steatosis involving 30% of hepatocytes. BMI 32, HA 60 µg/L, no ascites.
Explanation
The good example provides specific imaging findings and lab values supporting the diagnosis.

Need help with ICD-10 coding for Steatosis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more